Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.7K Hold
1,245
0.03% 171
2025
Q4
$61.1K Buy
1,245
+213
+21% +$9.93K 0.03% 204
2025
Q3
$44.5K Hold
1,032
0.02% 210
2025
Q2
$39.6K Sell
1,032
-331
-24% -$12.6K 0.02% 212
2025
Q1
$52.8K Sell
1,363
-292
-18% -$10.7K 0.03% 156
2024
Q4
$56K Sell
1,655
-945
-36% -$34K 0.04% 154
2024
Q3
$106K Hold
2,600
0.07% 99
2024
Q2
$100K Hold
2,600
0.07% 92
2024
Q1
$111K Hold
2,600
0.08% 82
2023
Q4
$96.4K Buy
+2,600
New +$93.3K 0.08% 88

Other funds holding GSK

WealthCollab's GSK Position: Q1 2026 in Review

WealthCollab held its GSK (GSK) position steady in Q1 2026 at 1,245 shares worth $68.7K. The position accounts for 0.03% of the portfolio, ranked #171.

WealthCollab first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. The position peaked at $111K in Q1 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • WealthCollab held 1,245 shares of GSK worth $68.7K as of Q1 2026.
  • WealthCollab left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.03% of WealthCollab's portfolio in Q1 2026, its #171 holding.
  • WealthCollab first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's GSK position peaked at $111K in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.